This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Antibioticos, S.a., Other. Active years: 1988-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-2004
Title: Santiago Conde Ruzafa: Innovator in Therapeutic Compounds
Introduction
Santiago Conde Ruzafa is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 3 patents, his work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents is a groundbreaking work titled "Compounds and their therapeutic use." This patent outlines a detailed process for the preparation of 3-chloro-cefem compounds. The process involves several stages, including the protection of functional groups of the side chain of Ampicillin, esterification of the acid group, oxidation to sulphoxide, and the expansion of the thiazole ring to a thiazine ring. Additionally, it includes ozonolysis of the exomethylene cefam derivative obtained, substitution of the hydroxyl group by chlorine, and de-protection of the functional groups. Notably, the order of some stages can be varied without affecting the final result.
Career Highlights
Santiago has worked with prominent companies in the pharmaceutical industry, including Antibioticos, S.A. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in drug development.
Collaborations
Throughout his career, Santiago has collaborated with talented individuals such as Ana Martinez Gil and Daniel Ignacio Perez Fernandez. These partnerships have fostered a creative environment that has led to significant advancements in their respective fields.
Conclusion
Santiago Conde Ruzafa is a distinguished inventor whose work in therapeutic compounds continues to influence the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile